ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ORMP on Nasdaq
Type / Class
Equity / Common Stock par value $0.012 per share
Shares outstanding
41M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
7.24M
Holdings value
$19.1M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
46
Number of buys
13
Number of sells
-15
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KIDRON NADAV 7.6% $6.64M 3.12M Nadav Kidron 11 Feb 2025
BML Investment Partners, L.P. 6.55% $5.82M 2.64M BML Investment Partners, L.P. 31 Dec 2024

Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 7.24M $19.1M +$25.9K $2.64 46
2025 Q2 7.25M $16.3M -$1.13M $2.25 47
2025 Q1 7.77M $16.6M +$194K $2.14 52
2024 Q4 7.67M $18.6M +$1.15M $2.42 56
2024 Q3 6.96M $17M +$2.49M $2.44 55
2024 Q2 5.93M $15.2M +$1.73M $2.57 58
2024 Q1 5.26M $15.4M +$367K $2.92 51
2023 Q4 5.16M $11.9M +$6.48M $2.31 56
2023 Q3 2.29M $5.99M -$131K $2.61 55
2023 Q2 2.28M $8.15M -$6.05M $3.58 50
2023 Q1 4.26M $9.29M -$8.6M $2.18 58
2022 Q4 3.6M $43.3M +$3.05M $12.03 75
2022 Q3 3.94M $25.5M -$15.5M $6.48 66
2022 Q2 6.65M $30.6M -$17.8M $4.58 81
2022 Q1 9.03M $78.3M -$349K $8.65 99
2021 Q4 8.58M $122M +$40.9M $14.28 114
2021 Q3 5.41M $119M +$35.5M $21.98 91
2021 Q2 3.84M $51.4M +$35.1M $13.38 73
2021 Q1 1.24M $64.2M +$52.4M $10.16 43
2020 Q4 1.46M $6.17M -$1.61M $4.24 36
2020 Q3 2M $5.19M +$1.67M $2.61 34
2020 Q2 1.35M $4.73M +$2.52M $3.53 31
2020 Q1 624K $1.9M -$91.4K $3.04 29
2019 Q4 624K $3.22M -$401K $5.14 30
2019 Q3 759K $2.42M -$260K $3.19 28
2019 Q2 839K $3.01M -$842K $3.59 26
2019 Q1 1.07M $3.91M -$2.62M $3.64 25
2018 Q4 1.9M $5.7M +$413K $3.00 24
2018 Q3 1.74M $8.45M +$7.17M $4.85 28
2018 Q2 263K $1.96M +$6.4K $7.43 21
2018 Q1 256K $1.67M -$821K $6.51 20
2017 Q4 378K $3.4M +$790K $9.00 27
2017 Q3 275K $2.73M +$1.26M $9.92 22
2017 Q2 149K $1.16M +$277K $7.78 21
2017 Q1 148K $909K +$37.7K $6.11 20
2016 Q4 139K $850K -$375K $6.05 23
2016 Q3 182K $1.32M -$246K $7.26 21
2016 Q2 221K $1.84M +$300K $8.34 23
2016 Q1 201K $1.32M -$124K $6.65 24
2015 Q4 210K $1.78M +$388K $8.55 23
2015 Q3 156K $854K -$1.04M $5.47 18
2015 Q2 335K $1.9M -$1.48M $5.68 13
2015 Q1 544K $3.37M -$1.23M $6.37 14
2014 Q4 824K $3.76M -$865K $4.56 19
2014 Q3 1.38M $11.1M -$424K $8.07 18
2014 Q2 1.43M $13.7M +$928K $9.62 22
2014 Q1 1.31M $15.3M +$5.08M $11.78 21